Allergic Bronchopulmonary Aspergillosis (ABPA)
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction to Aspergillus species, which are common fungi found in the environment. This condition occurs when the immune system overreacts to the presence of Aspergillus, leading to inflammation and damage in the lungs.
Causes and Risk Factors
ABPA is most commonly seen in people with asthma or cystic fibrosis, as these conditions can increase the risk of developing an allergic reaction to Aspergillus. The exact cause of ABPA is not fully understood, but it is thought to involve a combination of genetic and environmental factors.
Symptoms
The symptoms of ABPA can vary in severity and may include:
- Coughing, which can produce plugs of mucus or blood
- Wheezing or shortness of breath
- Chest pain or tightness
- Fever
- Weight loss
- Fatigue
Diagnosis
Diagnosing ABPA can be challenging, as the symptoms are similar to those of other respiratory conditions. A diagnosis is typically made based on a combination of:
- Clinical history and physical examination
- Imaging tests, such as chest X-rays or CT scans
- Pulmonary function tests (PFTs) to assess lung function
- Blood tests to detect the presence of Aspergillus antibodies
- Sputum tests to detect the presence of Aspergillus
Treatment
Treatment for ABPA typically involves a combination of:
- Corticosteroids to reduce inflammation and suppress the immune system
- Antifungal medications to eliminate the Aspergillus infection
- Bronchodilators to help manage asthma symptoms
- Oxygen therapy to help improve lung function
Complications
If left untreated, ABPA can lead to serious complications, including:
- Chronic bronchiectasis (damage to the airways)
- Pulmonary fibrosis (scarring of the lungs)
- Respiratory failure
Prevention
While it is not possible to completely prevent ABPA, there are steps that can be taken to reduce the risk of developing the condition:
- Avoiding exposure to Aspergillus by wearing a mask when working with soil or compost
- Using air purifiers to reduce mold spores in the home
- Managing asthma and cystic fibrosis symptoms effectively
Frequently Asked Questions (FAQs)
What is allergic bronchopulmonary aspergillosis (ABPA)?
A condition where the airways react to a fungus called Aspergillus.
What causes ABPA?
Inhaling Aspergillus spores triggers an allergic reaction.
Who is at risk for ABPA?
People with asthma or cystic fibrosis are more susceptible.
What are the symptoms of ABPA?
Coughing, wheezing, chest tightness, and fever.
How is ABPA diagnosed?
Through blood tests, lung function tests, and imaging studies.
Can ABPA be treated?
Yes, with corticosteroids and antifungal medications.
What are the complications of untreated ABPA?
Bronchiectasis, pulmonary fibrosis, and respiratory failure.
Is ABPA contagious?
No, it is not contagious.
Can ABPA be prevented?
Avoiding exposure to Aspergillus spores may help prevent ABPA.
What is the prognosis for people with ABPA?
Good with proper treatment and management.
Article last updated on: 25th June 2025.
If you have any feedback, please get in touch.
See more
Diagnosis Pad
Medical AI Assistant with Differentials, Guidance, Transcriptions, Notes, Medical Encyclopedia and Explainable AI.
Medical AI Assistant with Differentials, Guidance, Transcriptions, Notes, Medical Encyclopedia and Explainable AI.
Medical Disclaimer
The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site. We we do not guarantee, and assume no legal liability or responsibility for the accuracy, currency, or completeness of the information provided.